Diabetic Kidney disease
Conditions
Interventions
None listed
Sponsors
Edogawa Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients aged 18 years and older at the time of obtaining consent. Patients who, prior to the initiation of the observational study, received a thorough explanation from the principal investigator or the responsible physician (referred to as "attending physician") about the purpose, content, and anticipated secondary effects of the study, and who, after a comprehensive understanding, voluntarily agreed to participate in the observational study and provided written consent for participation. Patients for whom written consent for participation in the study has been obtained personally.
Exclusion criteria
Exclusion criteria: Patients diagnosed with dementia. Patients with Type 1 diabetes, pregnant individuals, malignancies, and those suffering from chronic/acute infections. Patients with acute conditions requiring emergency intervention. Patients who have shown primary or secondary kidney disorders or symptoms prior to diabetes diagnosis. Patients diagnosed with alcohol or substance abuse within 3 months before signing the consent form. Patients whom the attending physician has deemed inappropriate for participation in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fetuin-A Fragment eGFR Albumin Creatinine | — |
Countries
Japan
Contacts
Public ContactTomohiro Maruta
Premedica Inc. Overseas Sales & Marketing Division
Outcome results
None listed